(Q44424378)

English

Pharmacokinetics of an Immediate‐Release Oral Formulation of Fampridine (4‐Aminopyridine) in Normal Subjects and Patients with Spinal Cord Injury

scientific article published on April 1, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Pharmacokinetics of an immediate-release oral formulation of Fampridine (4-aminopyridine) in normal subjects and patients with spinal cord injury (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Pharmacokinetics of an Immediate‐Release Oral Formulation of Fampridine (4‐Aminopyridine) in Normal Subjects and Patients with Spinal Cord Injury (English)

1 reference

10.1177/0091270003251388

https://api.crossref.org/works/10.1177/0091270003251388

29 December 2023

pharmacokinetics

1 reference

based on heuristic

inferred from title

1 reference

10.1177/0091270003251388

https://api.crossref.org/works/10.1177/0091270003251388

29 December 2023

author name string

Hsieh JT

4

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

K. C. Hayes

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12723458

29 December 2023

M. A. Katz

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12723458

29 December 2023

J. G. Devane

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12723458

29 December 2023

J. T C. Hsieh

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12723458

29 December 2023

D. L. Wolfe

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12723458

29 December 2023

P. J. Potter

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12723458

29 December 2023

A. R. Blight

7

0009-0006-8616-6264

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12723458

29 December 2023

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12723458

29 December 2023

publication date

1 April 2003

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1177%2F0091270003251388

1 reference

10.1177/0091270003251388

https://api.crossref.org/works/10.1177/0091270003251388

29 December 2023

https://accp1.onlinelibrary.wiley.com/doi/pdf/10.1177/0091270003251388

1 reference

10.1177/0091270003251388

https://api.crossref.org/works/10.1177/0091270003251388

29 December 2023

The Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

43

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

379-385

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Intravenous infusion of 4-AP in chronic spinal cord injured subjects.

1 reference

https://api.crossref.org/works/10.1177%2F0091270003251388

21 January 2018

Intrathecal administration of 4-aminopyridine in chronic spinal injured patients.

1 reference

https://api.crossref.org/works/10.1177%2F0091270003251388

21 January 2018

Safety and efficacy of 4-aminopyridine in humans with spinal cord injury: a long-term, controlled trial

1 reference

https://api.crossref.org/works/10.1177%2F0091270003251388

21 January 2018

Randomized trial of 4-aminopyridine in patients with chronic incomplete spinal cord injury

1 reference

https://api.crossref.org/works/10.1177%2F0091270003251388

21 January 2018

The effects of 4-aminopyridine in multiple sclerosis patients: results of a randomized, placebo-controlled, double-blind, concentration-controlled, crossover trial.

1 reference

https://api.crossref.org/works/10.1177%2F0091270003251388

21 January 2018

Orally administered 4-aminopyridine improves clinical signs in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F0091270003251388

21 January 2018

4-Aminopyridine is superior to 3,4-diaminopyridine in the treatment of patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F0091270003251388

21 January 2018

Quantitative assessment of sustained-release 4-aminopyridine for symptomatic treatment of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F0091270003251388

21 January 2018

4-Aminopyridine in Patients with Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F0091270003251388

21 January 2018

Physiological effects of 4-aminopyridine on demyelinated mammalian motor and sensory fibers

1 reference

https://api.crossref.org/works/10.1177%2F0091270003251388

21 January 2018

Effects of 4-aminopyridine on normal and demyelinated mammalian nerve fibres

1 reference

https://api.crossref.org/works/10.1177%2F0091270003251388

21 January 2018

4-Aminopyridine leads to restoration of conduction in demyelinated rat sciatic nerve.

1 reference

https://api.crossref.org/works/10.1177%2F0091270003251388

21 January 2018

The mode of action of 4-aminopyridine and guanidine on transmitter release from motor nerve terminals

1 reference

https://api.crossref.org/works/10.1177%2F0091270003251388

21 January 2018

Effects of 4-aminopyridine on transmission in excitatory and inhibitory synapses in the spinal cord

1 reference

https://api.crossref.org/works/10.1177%2F0091270003251388

21 January 2018

Gating-dependent mechanism of 4-aminopyridine block in two related potassium channels

1 reference

https://api.crossref.org/works/10.1177%2F0091270003251388

21 January 2018

Absorption characteristics of sustained-release 4-aminopyridine (fampridine SR) in patients with chronic spinal cord injury

1 reference

https://api.crossref.org/works/10.1177%2F0091270003251388

21 January 2018

Poisoning with 4-Aminopyridine: Report of Three Cases

1 reference

https://api.crossref.org/works/10.1177%2F0091270003251388

21 January 2018

Effective treatment of verapamil intoxication with 4-aminopyridine in the cat.

1 reference

https://api.crossref.org/works/10.1177%2F0091270003251388

21 January 2018

Treatment of verapamil toxicity in intact dogs

1 reference

https://api.crossref.org/works/10.1177%2F0091270003251388

21 January 2018

Effects of 4-aminopyridine on motor evoked potentials in patients with spinal cord injury: a double-blinded, placebo-controlled crossover trial

1 reference

https://api.crossref.org/works/10.1177%2F0091270003251388

21 January 2018

Preclinical trial of 4-aminopyridine in patients with chronic spinal cord injury

1

1 reference

10.1177/0091270003251388

https://api.crossref.org/works/10.1177/0091270003251388

29 December 2023

4-Aminopyridine in chronic spinal cord injury: a controlled, double-blind, crossover study in eight patients

4

1 reference

10.1177/0091270003251388

https://api.crossref.org/works/10.1177/0091270003251388

29 December 2023

4-Aminopyridine-sensitive neurologic deficits in patients with spinal cord injury

6

1 reference

10.1177/0091270003251388

https://api.crossref.org/works/10.1177/0091270003251388

29 December 2023

4-Aminopyridine alters gait characteristics and enhances locomotion in spinal cord injured humans.

8

1 reference

10.1177/0091270003251388

https://api.crossref.org/works/10.1177/0091270003251388

29 December 2023

Sustained improvements in neurological function in spinal cord injured patients treated with oral 4-aminopyridine: three cases

11

1 reference

10.1177/0091270003251388

https://api.crossref.org/works/10.1177/0091270003251388

29 December 2023

Randomized double-blind crossover trial of fampridine-SR (sustained release 4-aminopyridine) in patients with incomplete spinal cord injury

12

1 reference

10.1177/0091270003251388

https://api.crossref.org/works/10.1177/0091270003251388

29 December 2023

Mechanism of action of 4-aminopyridine in the symptomatic treatment of multiple sclerosis

15

1 reference

10.1177/0091270003251388

https://api.crossref.org/works/10.1177/0091270003251388

29 December 2023

4-aminopyridine in the treatment of patients with multiple sclerosis. Long-term efficacy and safety

16

1 reference

10.1177/0091270003251388

https://api.crossref.org/works/10.1177/0091270003251388

29 December 2023

4-Aminopyridine improves clinical signs in multiple sclerosis

19

1 reference

10.1177/0091270003251388

https://api.crossref.org/works/10.1177/0091270003251388

29 December 2023

4-Aminopyridine in multiple sclerosis: prolonged administration

20

1 reference

10.1177/0091270003251388

https://api.crossref.org/works/10.1177/0091270003251388

29 December 2023

4-Aminopyridine induces functional improvement in multiple sclerosis patients: a neurophysiological study

21

1 reference

10.1177/0091270003251388

https://api.crossref.org/works/10.1177/0091270003251388

29 December 2023

The effect of 4-aminopyridine on clinical signs in multiple sclerosis: a randomized, placebo-controlled, double-blind, cross-over study

23

1 reference

10.1177/0091270003251388

https://api.crossref.org/works/10.1177/0091270003251388

29 December 2023

The effects of 4‐aminopyridine and tetraethylammonium ions on normal and demyelinated mammalian nerve fibres

24

1 reference

10.1177/0091270003251388

https://api.crossref.org/works/10.1177/0091270003251388

29 December 2023

Differential effects of low and high concentrations of 4-aminopyridine on axonal conduction in normal and injured spinal cord

27

1 reference

10.1177/0091270003251388

https://api.crossref.org/works/10.1177/0091270003251388

29 December 2023

Effect of 4-aminopyridine on axonal conduction-block in chronic spinal cord injury

29

1 reference

10.1177/0091270003251388

https://api.crossref.org/works/10.1177/0091270003251388

29 December 2023

Effects of 4-aminopyridine on motor evoked potentials in patients with spinal cord injury

34

1 reference

10.1177/0091270003251388

https://api.crossref.org/works/10.1177/0091270003251388

29 December 2023

Human botulism caused by Clostridium botulinum type E: the Birmingham outbreak

36

1 reference

10.1177/0091270003251388

https://api.crossref.org/works/10.1177/0091270003251388

29 December 2023

Treatment with oral 4-aminopyridine in disorders of neuromuscular transmission

37

1 reference

10.1177/0091270003251388

https://api.crossref.org/works/10.1177/0091270003251388

29 December 2023

Effects of 4-Aminopyridine in Elderly Patients with Alzheimer’s Disease

39

1 reference

10.1177/0091270003251388

https://api.crossref.org/works/10.1177/0091270003251388

29 December 2023

Characterization of 4-aminopyridine in overdose

42

1 reference

10.1177/0091270003251388

https://api.crossref.org/works/10.1177/0091270003251388

29 December 2023

Pharmacokinetics of 4-aminopyridine in human volunteers. A preliminary study using a new GLC method for its estimation

43

1 reference

10.1177/0091270003251388

https://api.crossref.org/works/10.1177/0091270003251388

29 December 2023

4-Aminopyridine kinetics

44

1 reference

10.1177/0091270003251388

https://api.crossref.org/works/10.1177/0091270003251388

29 December 2023

Molecular biology of voltage-dependent potassium channels

45

1 reference

10.1177/0091270003251388

https://api.crossref.org/works/10.1177/0091270003251388

29 December 2023

4-Aminopyridine Potentiates Neostigmine and Pyridostigmine in Man

49

1 reference

10.1177/0091270003251388

https://api.crossref.org/works/10.1177/0091270003251388

29 December 2023

The effects of 4-aminopyridine on motor evoked potentials in multiple sclerosis

52

1 reference

10.1177/0091270003251388

https://api.crossref.org/works/10.1177/0091270003251388

29 December 2023

Overview of patient compliance with medication dosing: a literature review

54

1 reference

10.1177/0091270003251388

https://api.crossref.org/works/10.1177/0091270003251388

29 December 2023

Identifiers

10.1177/0091270003251388

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44424378&oldid=2107923267"